Russell Investments Group Ltd. boosted its stake in shares of CME Group Inc (NASDAQ:CME) by 53.7% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 615,226 shares of the financial services provider’s stock after buying an additional 214,893 shares during the period. Russell Investments Group Ltd. owned about 0.18% of CME Group worth $73,097,000 at the end of the most recent quarter.
Several other hedge funds have also recently bought and sold shares of the stock. Huntington National Bank boosted its position in shares of CME Group by 4.7% in the first quarter. Huntington National Bank now owns 851 shares of the financial services provider’s stock valued at $100,000 after buying an additional 38 shares during the period. Johnson Financial Group Inc. boosted its position in shares of CME Group by 5.9% in the fourth quarter. Johnson Financial Group Inc. now owns 899 shares of the financial services provider’s stock valued at $104,000 after buying an additional 50 shares during the period. Parallel Advisors LLC bought a new position in shares of CME Group during the fourth quarter valued at about $120,000. Archford Capital Strategies LLC boosted its position in shares of CME Group by 5,492.0% in the fourth quarter. Archford Capital Strategies LLC now owns 1,398 shares of the financial services provider’s stock valued at $161,000 after buying an additional 1,373 shares during the period. Finally, Advisors Preferred LLC bought a new position in shares of CME Group during the third quarter valued at about $180,000. 80.06% of the stock is owned by institutional investors and hedge funds.
CME Group Inc (NASDAQ:CME) traded up 0.93% during trading on Friday, reaching $116.19. The company’s stock had a trading volume of 1,904,593 shares. CME Group Inc has a 52 week low of $92.00 and a 52 week high of $127.60. The stock has a market capitalization of $39.31 billion, a price-to-earnings ratio of 25.15 and a beta of 0.88. The firm has a 50 day moving average of $119.38 and a 200 day moving average of $116.51.
CME Group (NASDAQ:CME) last released its earnings results on Thursday, April 27th. The financial services provider reported $1.22 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.20 by $0.02. The firm had revenue of $929 million for the quarter, compared to the consensus estimate of $932.06 million. CME Group had a return on equity of 7.28% and a net margin of 42.67%. The company’s revenue for the quarter was down .5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.15 EPS. Analysts expect that CME Group Inc will post $4.86 EPS for the current year.
Several equities analysts recently issued reports on CME shares. Deutsche Bank AG restated a “buy” rating and issued a $134.00 price target (down previously from $137.00) on shares of CME Group in a research report on Friday. Zacks Investment Research cut CME Group from a “hold” rating to a “sell” rating in a research report on Wednesday, March 8th. Jefferies Group LLC restated a “buy” rating and issued a $128.00 price target on shares of CME Group in a research report on Saturday, March 11th. JPMorgan Chase & Co. cut CME Group from an “overweight” rating to a “neutral” rating in a research report on Tuesday, January 31st. Finally, Royal Bank of Canada dropped their target price on CME Group from $134.00 to $133.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 19th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and five have given a buy rating to the stock. CME Group presently has a consensus rating of “Hold” and an average price target of $111.29.
In other CME Group news, Director Ronald A. Pankau sold 500 shares of the company’s stock in a transaction on Friday, February 24th. The stock was sold at an average price of $122.11, for a total value of $61,055.00. Following the transaction, the director now owns 3,500 shares of the company’s stock, valued at approximately $427,385. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Hilda Harris Piell sold 3,043 shares of the company’s stock in a transaction on Tuesday, March 14th. The shares were sold at an average price of $124.26, for a total value of $378,123.18. Following the completion of the transaction, the insider now directly owns 26,082 shares in the company, valued at approximately $3,240,949.32. The disclosure for this sale can be found here. In the last three months, insiders have sold 14,030 shares of company stock worth $1,702,964. Corporate insiders own 0.61% of the company’s stock.
CME Group Company Profile
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).